COPD - Free CE Continuing Education online pharmacy, pharmacists

More documents

Recommendations

Info

• Central to symptomatic management • PRN or scheduled based on severity • Inhaled route preferred – fewer adverse effects • Includes: β2‐ agonists, anticholinergics and methylxanthines • All increase exercise capacity • Long‐acting forms more effective and convenient
Page 1 and 2: Women Beware The Threat of COPD Cat
Page 3 and 4: Women Beware The Threat of COPD Acc
Page 5 and 6: Chronic obstructive pulmonary disea
Page 7 and 8: Clinical Presentation of COPD • S
Page 9 and 10: COPD - Defining Characteristics Spi
Page 11 and 12: Diagnosis of COPD in Women 80 70 60
Page 13 and 14: • Estimated 24 million adults wit
Page 15 and 16: • Tobacco use is the #1 cause of
Page 17 and 18: • Genetic - severe heredity defic
Page 19 and 20: Treatment Pathway
Page 22 and 23: Non Pharmacologic Therapy
Page 24 and 25: Vaccines • Flu: Annual influenza
Page 28 and 29: Medication Class Bronchodilator- Sh
Page 30 and 31: Medication Class Brand Generic Avai
Page 32 and 33: • Low dose theophylline reduces e
Page 34 and 35: Inhaled Steroids Medication Class B
Page 36 and 37: • Inquire about and recommend spi
Page 38 and 39: 66 yo woman visits PCP for a linger
Page 40 and 41: 66 yo woman visits PCP for a linger
Page 42: Conclusion • Improve diagnosis of

COPD - Free CE Continuing Education online pharmacy, pharmacists

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?